In this context, the present study utilized clinical cohort analysis to explore the relationship between ApoA-I levels and the progression-free survival (PFS) and overall survival (OS) of patients with CRC who underwent surgical treatment. This evidence concerns the gene APOA1 and colorectal carcinoma.